PositiveID Corporation (fka PSID)

[Micheal Stocks]

Read this:

PositiveID (OTC: PSID) is our Small Cap pick for the next 12 months. PSID is a company blazing trails and turning an industry on its head. PSID is a medical device company developing the Firefly Dx, a handheld device that is essentially a “lab in the hand,” which, when fully developed, could test anyone or anything for contamination or disease ranging from Ebola, to E.coli, to influenza, to MRSA, and more at the point of care. The Firefly Dx is being designed to test for any of these pathogens, from the palm of the user’s hand, within 20 minutes at a much lower cost than existing methods. Traditionally if one wanted to test a person, an item or even food for contamination, they would have to take a sample to a lab (which in and of itself adds significant time and puts the sample at risk for contamination) which takes a minimum of 4 hours to provide results, and is very expensive.

To our knowledge, this is a one-of-a-kind product that would address a significant portion of a $27 billion market (or segments thereof). The breadth of usage of the Firefly Dx can be very broad as it can be used in humanitarian/homeland defense to guard against spreading of pathogens such as Ebola; in hospitals/clinics to test equipment, etc., for devastating pathogens such as MRSA before spreading; in a doctor’s office to give immediate results for influenza (by strain); or in any food processing facility to perform frequent checks on produce/meats to prevent recalls for pathogens such as E.Coli which are PR disasters for these companies.

This company is development stage, but has very serious potential upside as it trades slightly under $0.03 per share at an overall market cap of roughly $9.5 million. Once commercialized, even if the Firefly Dx garnered a small amount of market penetration, we feel the Company could be worth 10 – 100X what it’s trading at now, based on industry price-to-sales multiples.

PSID has been making recent and frequent updates on the development of the Firefly Dx and also recently announced a strategic financing from an institutional investor, which is funding the development program for this unit to commercialization— a great time to be in and around this name. View PSID’s stock quote and news here: http://goo.gl/vyi9iN

http://wealthyventurecapitalist.com/2015/10/01/healthcare-and-biotech-stocks-are-making-a-bottom-4-forever-stocks-smart-investors-are-buying-on-the-dip/